Take a timeout2vote for Your Favorite NCAA Coach in the INFINITI Coaches' Charity Challenge

NASHVILLE, TN—(Marketwired – January 08, 2018) –

  • INFINITI introduces new #timeout2vote campaign to launch eighth–annual Coaches' Charity Challenge
  • From January to March, 48 NCAA® basketball coaches compete to raise $349,000 for local charities
  • Fan votes determine winning coach receiving a $100,000 donation from INFINITI

INFINITI kicks off the most exciting season for college basketball with the “INFINITI Coaches' Charity Challenge” and a new creative campaign that encourages fans to take a #timeout2vote for their favorite coaches and charities.

The INFINITI Coaches' Charity Challenge is a unique aspect of the brand's partnership with the National Association of Basketball Coaches (NABC), the NCAA® and ESPN. At the start, 48 NCAA® Division I men's basketball coaches compete for fan votes in a four–round contest that raises money for charities of the coaches' choice.

INFINITI, an official corporate partner of the NCAA, will make donations throughout the competition totaling $349,000. The further the coaches advance in the competition, the more money they raise for their respective charities. The winning coach will receive $100,000 to benefit his charity of choice.

“The INFINITI Coaches' Charity Challenge provides the perfect platform for college basketball coaches and fans to work as a team, providing significant financial support and awareness for so many worthy charitable initiatives,” said Jim Haney, NABC executive director. “Numerous national and local charitable organizations are the beneficiaries of the outstanding contributions made throughout the year by college basketball coaches across the country.”

While only one coach will win the grand prize, INFINITI has guaranteed each coach a donation of at least $1,000 to his chosen charitable organization.

Take a timeout2vote

Beginning Jan. 2, fans will decide the winner over a 10–week period by casting votes at www.infinititimeout.com. Supporters can cast one vote per day for a coach's charity. For the first time, basketball fans will be able to vote via Instagram and Twitter using the hashtag #timeout2vote.

“Every year INFINITI looks forward to working with NABC, NCAA® and ESPN to raise money for charities with the INFINITI Coaches' Charity Challenge,” said Phil O'Connor, director, Marketing Communications and Media. “This year, our campaign focuses on the importance of timeouts both on and off the court, and we encourage fans to take a timeout from their daily lives to vote for their favorite coaches and their respective charities.”

The first round of voting takes place Jan. 2 and runs through Jan. 21, with half of the coaches advancing to a second round, held between Jan. 22 and Feb. 11. From Feb. 12 to 25, the 16 advancing coaches from round two will compete in a third round where only four coaches advance to the final, fourth round which takes place from Feb. 26 to March 10. The coach with the most votes, along with his chosen charity, will be announced on March 11.

“The INFINITI Coaches' Charity Challenge is a very successful program that connects our fan base and college coaches in a fun way to worthy organizations and foundations in local communities,” said Ellen Lucey, NCAA director of championships and alliances, corporate relations, marketing and brand. “We're pleased to be involved with the challenge this year as the program represents a way to return the support that is given to our member schools and our student–athletes.”

The challenge is further promoted across the ESPN digital and broadcast network including ESPN, ESPN2, ESPNU, ESPN.com and across several social media platforms.

The 48 coaches participating this year:

  • University of Alabama coach Avery Johnson, competing for Coaches vs. Cancer
  • University of Arizona coach Sean Miller, competing for Casa de los Niños
  • Arizona State University coach Bobby Hurley, competing for Pat Tillman Foundation
  • Auburn University coach Bruce Pearl, competing for Children's Harbor, Inc.
  • Baylor University coach Scott Drew, competing for Coaches vs. Cancer
  • BYU coach Dave Rose, competing for BYU Simmons Center for Cancer Research
  • Central Florida University coach Johnny Dawkins, competing for Boys and Girls Club of Central Florida
  • Clemson University coach Brad Brownell, competing for The Outdoor Dream Foundation
  • University of Colorado coach Tad Boyle, competing for Special Olympics Colorado
  • Creighton University coach Greg McDermott, competing for Abide
  • University of Florida coach Mike White, competing for UF Health Shands Children's Hospital
  • Georgia State University coach Ron Hunter, competing for Samaritan's Feet International
  • Georgia Tech coach Josh Pastner, competing for WellStar Foundation
  • Gonzaga University coach Mark Few, competing for Community Cancer Fund
  • University of Illinois coach Brad Underwood, competing for United Way of Champaign County
  • University of Indiana coach Archie Miller, competing for Indiana University Dance Marathon
  • University of Iowa coach Fran McCaffery, competing for Coaches vs. Cancer
  • Iowa State University coach Steve Prohm, competing for Lupus Foundation of America, Iowa Chapter
  • Kansas State University coach Bruce Weber, competing for Coaches vs. Cancer
  • LSU coach Will Wade, competing for Baton Rouge Youth Coalition
  • Marquette University coach Steve Wojciechowski, competing for Camp Hometown Heroes
  • University of Maryland coach Mark Turgeon, competing for Alzheimer's Association
  • University of Memphis coach Tubby Smith, competing for Tubby Smith Foundation
  • Michigan State University coach Tom Izzo, competing for Volunteers of America Michigan
  • University of Missouri coach Cuonzo Martin, competing for Boys & Girls Club of Columbia, Missouri
  • University of North Carolina coach Roy Williams, competing for UNC Lineberger Comprehensive Cancer Center
  • University of Notre Dame coach Mike Brey, competing for Coaches vs. Cancer
  • University of Oklahoma coach Lon Kruger, competing for Coaches vs. Cancer
  • University of Oregon coach Dana Altman, competing for Children's Miracle Network (CMN)
  • Providence College coach Ed Cooley, competing for Amos House
  • Purdue University coach Matt Painter, competing for Smith Family BReaK Thru Fund
  • University of South Carolina coach Frank Martin, competing for South Carolina Center for Fathers and Families
  • St. John's University coach Chris Mullin, competing for The Herren Project
  • St. Louis University coach Travis Ford, competing for Big Brothers Big Sisters of Eastern Missouri
  • Stanford University coach Jerod Haase, competing for Lucile Packard Children's Hospital Stanford
  • Stephen F. Austin State University coach Kyle Keller, competing for Nacogdoches Area United Way
  • Syracuse University coach Jim Boeheim, competing for Jim and Juli Boeheim Foundation
  • Texas Christian University coach Jamie Dixon, competing for Maggie Dixon Foundation
  • Temple University coach Fran Dunphy, competing for Big Brothers Big Sister Independence
  • University of Tennessee coach Rick Barnes, competing for Emerald Youth Foundation
  • UCLA coach Steve Alford, competing for Special Olympics Southern California
  • Vanderbilt University coach Bryce Drew, competing for Coaches vs. Cancer
  • Villanova University coach Jay Wright, competing for Augustinian Fund
  • University of Virginia coach Tony Bennett, competing for American Red Cross Virginia Region
  • Wake Forest University coach Danny Manning, competing for Special Olympics North Carolina
  • University of West Virginia coach Bob Huggins, competing for Norma Mae Huggins Cancer Research Endowment Fund
  • Wichita State University coach Gregg Marshall, competing for Wichita Children's Home
  • University of Wisconsin coach Greg Gard, competing for Garding Against Cancer

About INFINITI
INFINITI Motor Company Ltd. is headquartered in Hong Kong with representations in 50 markets around the world. The INFINITI brand was launched in 1989. Its range of premium automobiles is currently built in manufacturing facilities in Japan, the United States, United Kingdom and China. INFINITI design studios are located in Atsugi–Shi (near Yokohama), London, San Diego and Beijing. INFINITI is in the middle of a major product offensive. The brand has been widely acclaimed for its daring design and innovative driver–assistance technologies. From the 2016 season, INFINITI is a technical partner of the Renault Sport Formula One team, contributing its expertise in hybrid performance.

More information about INFINITI and its industry–leading technologies can be found at www.infiniti.com. You can also follow INFINITI on Facebook, Instagram, Twitter, LinkedIn and see all our latest videos on YouTube.

About NCAA
The NCAA is a membership–led nonprofit association of colleges and universities committed to supporting academic and athletic opportunities for more than 450,000 student–athletes at more than 1,000 member colleges and universities. Each year, more than 54,000 student–athletes compete in NCAA championships in Divisions I, II and III sports. Visit www.ncaa.org and www.ncaa.com for more details about the Association, its goals, members and corporate partnerships that help support programs for student–athletes. [NCAA is a trademark of the National Collegiate Athletic Association.]

About the National Association of Basketball Coaches
Located in Kansas City, Missouri, the NABC was founded in 1927 by Forrest “Phog” Allen, the legendary basketball coach at the University of Kansas. Allen, a student of James Naismith, the inventor of basketball, organized coaches into this collective group to serve as Guardians of the Game. The NABC currently has nearly 5,000 members consisting primarily of university and college men's basketball coaches. All members of the NABC are expected to uphold the core values of being a Guardian of the Game by bringing attention to the positive aspects of the sport of basketball and the role coaches play in the academic and athletic lives of today's student–athletes. The four core values of being a Guardian of the Game are advocacy, leadership, service and education. Additional information about the NABC, its programs and membership, can be found at www.nabc.org.

Image Available: http://www.marketwire.com/library/MwGo/2018/1/8/11G149267/Images/Timeout_Social_Infiniti_Static_FB–Twitter_V4–8c7e5639a2708fbb91d95eab4fcbb56f.jpg

Artisanal Brands, Inc.: Transition to New Operations; Returning to Full-Reporting SEC Status

NEW YORK, NY—(Marketwired – January 08, 2018) – Artisanal Brands, Inc. (OTCQB: AHFP) has entered into a transitional operating agreement with its current licensee effective January 1, 2018. This agreement will start Artisanal's transition into its expansion plan as a direct–to–consumer business focused on its online business and select cheese shop & cafes that will serve as regional shipping hubs. The natural and specialty cheese category is expected to exceed $19 billion this year and Artisanal is seeking to drive greater scale in its online business and new retail outlets by offering reduced shipping rates for overnight deliveries of the finest quality cave–aged cheeses sold online at www.artisanalcheese.com.

The company's senior lender has agreed to provide the financing needed during the transition period while the company continues to complete a new equity offering to fund the establishment of the 1st retail location. The short–term transition funding plan contemplates the recapitalization of the company's early–stage loans and conversion of its Series A preferred stock subject to shareholder approval.

Artisanal plans to use RBSM, LLC again as its outside independent auditors and will become a fully–reporting SEC filer in 2018.

The company has initiated a site selection plan and has located a property in midtown Manhattan for its first outlet targeted for Spring, 2018 subject to the closure of its funding plans.

About Artisanal Brands, Inc.
The Artisanal Premium Cheese line of products is sold to food wholesalers and retailers, and directly to consumers through the website, www.artisanalcheese.com.

Safe Harbor Statement
Forward–looking statements made in this press release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. They are based on management's expectations that involve potential risks and uncertainties (more fully described in Company filings made with the U.S. Securities and Exchange Commission) that may result in such expectations not being realized.

EnWave Signs Technology Evaluation and License Option Agreement with Seven Seas Fish Company Limited

VANCOUVER, BC—(Marketwired – January 08, 2018) – EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) (“EnWave”, or the “Company”) announced today that it has signed a Technology Evaluation and License Option Agreement (the “TELOA”) with Seven Seas Fish Company Limited (“Seven Seas”), a leading Canadian seafood manufacturer and international distributor.

The TELOA grants Seven Seas an exclusive six–month term to evaluate the use of Radiant Energy Vacuum (“REV™”) technology for the production of high–value, premium fin fish and other seafood snacks in British Columbia, Canada. A small–scale REV™ machine will be installed at Seven Seas' facility in February 2018, which will trigger the commencement of the exclusive term.

Prior to signing the TELOA, EnWave and Seven Seas conducted several product development tests at the Company's pilot plant that yielded positive results. REV™ technology has proven to work effectively in the dehydration of salmon, prawns, lobster, crab, scallops, mussels, oysters, sea cucumbers and other various seafood products.

About Seven Seas Fish
Seven Seas is a fish company that processes and distributes fresh, frozen and value added seafoods to a wide array of customer types in Canada and around the world. Full seafood distribution to retail, food service and wholesale distributors and a growing smoked and valued added line of sustainable, high quality seafoods. It sources seafood locally buying directly from fishers, but also globally buying from processors in several different countries. The company was founded in 1967 with its head office in Richmond, British Columbia, Canada. Seven Seas is a proven industry leader. For more information please visit www.7seas.ca.

About EnWave
EnWave Corporation, a Vancouver–based advanced technology company, has developed Radiant Energy Vacuum (“REV™”) — an innovative, proprietary method for the precise dehydration of organic materials. REV™ technology's commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, legal cannabis and pharmaceutical sectors. EnWave's strategy is to sign royalty–bearing commercial licenses with industry leaders in multiple verticals for the use of REV™ technology. The company has signed over twenty royalty–bearing licenses to date, opening up eight distinct market sectors for commercialization of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all–natural cheese snack products in the United States under the Moon Cheese® brand.

EnWave has introduced REV™ as the new dehydration standard in the food and biological material sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV™ platforms:

1. nutraREV® which is used in the food industry to dry food products quickly and at low–cost, while maintaining high levels of nutrition, taste, texture and colour;

2. powderREV® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and

3. quantaREV® which is used for continuous, high–volume low–temperature drying.

An additional platform, freezeREV®, is being developed as a new method to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation
Dr. Tim Durance
President & CEO

Safe Harbour for Forward–Looking Information Statements: This press release may contain forward–looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward–looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward–looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Advanced Proteome Therapeutics and Heidelberg Pharma Progress Collaborative Program

VANCOUVER, BC and LADENBURG, GERMANY—(Marketwired – January 08, 2018) – Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and Heidelberg Pharma announced today advances in their collaborative activities. The companies have agreed to test the combination of APC's proprietary site–selective protein modification technology and Heidelberg Pharma's proprietary ATAC technology in order to generate superior cancer therapeutics.

Since the inception of the partnership, activities have been centered on antibody–amanitin conjugates that are produced using controlled conjugation methods and possess high target–specific cytotoxic potency. The companies have successfully demonstrated the generation of ATACs using APC's proprietary protein modification technology.

“In a first step, we have succeeded in producing ADCs that are sufficiently cytotoxic to target–expressing cancer cell lines to proceed to the next level of in vivo testing. Results obtained from this collaboration will help us to increase the efficacy of our ATACs”, commented Professor Andreas Pahl, CSO of Heidelberg Pharma.

“We are delighted that the partnership with Heidelberg Pharma has generated positive results and look forward to continuing our work together, to the benefit of both companies”, commented Randal Chase, CEO of Advanced Proteome Therapeutics.

APC's technology aims at the coupling of a cytotoxic payload site–selectively to an antibody of interest without the necessity of genetically engineering such antibody. This may lead to more homogeneous products with certain additional advantages such as an increase in stability in the circulation, fewer side effects and facilitating further pre–clinical and clinical drug development.

About Advanced Proteome Therapeutics

Advanced Proteome Therapeutics Corporation (APC) (TSX VENTURE: APC) (FRANKFURT: 0E8) is developing a proprietary technology to directly target cancerous tumors and avoid destroying normal cells. This type of agent is capable of greater potency, higher specificity, and lower toxicity than other therapies that can also attack healthy cells. Advanced Proteome is working to streamline the process by which these agents are prepared, which to date, has been extremely cumbersome, limiting their potential. www.advancedproteome.com

About Heidelberg Pharma

Heidelberg Pharma AG is a biopharmaceutical company based in Ladenburg, Germany. Heidelberg Pharma is an oncology specialist and the first company to develop the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology and to advance the biological mode of action of the toxin as a novel therapeutic principle. This proprietary technology platform is being applied to develop the Company's proprietary therapeutic ATACs as well as in third–party collaborations to create a variety of ATAC candidates. The proprietary lead candidate HDP–101 is a BCMA ATAC for multiple myeloma. The Company has entered into partnerships to further develop and commercialize its clinical assets MESUPRON® and REDECTANE®, while RENCAREX® is available for out–licensing and further development. Heidelberg Pharma AG is listed on the Frankfurt Stock Exchange: ISIN DE000A11QVV0 / WKN A11QVV / Symbol WL6. More information is available at www.heidelberg–pharma.com.

Heidelberg Pharma

Heidelberg Pharma AG

Sylvia Wimmer

Tel.: +49 89 41 31 38–29

Email: investors[at]hdpharma.com

Schriesheimer Str. 101, 68526 Ladenburg
Germany
IR/PR support

MC Services AG

Katja Arnold (CIRO)

Managing Director & Partner

Tel.: +49 89–210 228–40

Email: katja.arnold[at]mc–services.eu

Heidelberg Pharma Research GmbH

Business Development

Dr. Marcel Linssen
CBO, Executive Vice President

Tel.: +49 6203 1009–40

Email: m.linssen[at]hdpharma.com

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This communication contains certain forward–looking statements relating to the Company's business, which can be identified by the use of forward–looking terminology such as “estimates”, “believes”, “expects”, “may”, “will”, “should”, “future”, “potential” or similar expressions or by a general discussion of the Company's strategies, plans or intentions. Such forward–looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results of operations, financial position, earnings, achievements, or industry results, to be materially different from any future results, earnings or achievements expressed or implied by such forward–looking statements. Given these uncertainties, prospective investors and partners are cautioned not to place undue reliance on such forward–looking statements. We disclaim any obligation to update any such forward–looking statements to reflect future events or developments.

Applied Minerals Enters into Exploration Agreement with Continental Mineral Claims, Inc.

NEW YORK, NY—(Marketwired – January 08, 2018) – Applied Minerals, Inc. (the “Company” or “Applied Minerals”) (OTCQB: AMNL), a leading global producer of halloysite clay and advanced natural iron oxides has entered into an Exploration Agreement with Option to Purchase (“Agreement”) with Continental Mineral Claims (“CMC”) for metallic minerals believed to be located at depths significantly below its current and future halloysite and iron oxide operations at the Dragon Mine. CMC is a wholly–owned subsidiary of a private, internationally recognized minerals exploration and mining company.

Under the terms of the Agreement, CMC has been granted an exclusive, 10–year license by Applied Minerals to conduct exploration activities for metallic minerals at Applied Minerals' Dragon Mine property, located in the Tintic District of Utah, USA. The Agreement contains protections in favor of the Company against unreasonable interference of its current and future halloysite and iron oxide mining operations.

CMC will pay Applied Minerals an upfront license fee of $350,000, an additional $150,000 at the first anniversary of the renewal of the license, and $250,000 annually thereafter upon renewal of the license by CMC. Additionally, Applied Minerals has granted CMC an option to purchase a 100% interest exclusively in the metallic mineral rights of the Dragon Mine for a cash purchase price of $3.0 million. The agreement does not contemplate the sale of any non–metallic minerals such as, but not limited to, halloysite or iron oxide located at the Dragon Mine property.

If CMC exercises the purchase option, Applied Minerals will be granted a 5% Net Profits Interest (“NPI”) royalty from any metallic production from the Dragon Mine property. Initially, the NPI will be capped at $20.0 million. The Company may opt to reduce the cap on its NPI to $10.0 million in exchange for $2.0 million worth of shares in a future public company formed or designated by CMC to own and operate CMC's Tintic District Project, up to a maximum of 2.0% of the equity in the future public company.

As part of the Agreement, CMC will (i) provide Applied Minerals with any drilling information and/or samples, related to the Dragon Mine's halloysite and iron oxide resources that it may obtain during its exploration activities and (ii) not unreasonably interfere with Applied Minerals' current and possible future halloysite and iron oxide mining operations.

CMC has up to forty (40) days following the effective date of the Agreement (“Due Diligence Period”) to perform any necessary due diligence in order to evaluate the condition and title of the mining claims included in the Agreement. CMC may terminate the Agreement at any time during the Due Diligence Period by written notice to APML.

About Applied Minerals

Applied Minerals is the leading producer of halloysite clay and advanced natural iron oxide solutions from its wholly owned Dragon Mine property in Utah. Halloysite is aluminosilicate clay that forms naturally occurring nanotubes. In addition to serving the traditional halloysite markets for use in technical ceramics and catalytic applications, the Company has developed niche applications that benefit from the tubular morphology of its halloysite. These applications include carriers of active ingredients in paints, coatings and building materials, environmental remediation, agricultural applications and high–performance additives and fillers for plastic composites. Applied Minerals markets its halloysite products under the DRAGONITE™ trade name.

From its Dragon Mine property, the Company also produces a range of ultra–pure natural iron oxides consisting of hematite and goethite. Combining ultra–high purity and consistent quality, the inherent properties of the iron oxide from the Dragon Mine allow for a wide range of end uses in pigment and technical applications. Applied Minerals markets its comprehensive line of advanced natural iron oxide pigments under the AMIRON™ trade name. Additional information on the Company can be found at www.appliedminerals.com and www.AMIRONoxides.com.

Continental Mineral Claims, Inc.

Continental Mineral Claims Inc. is a wholly owned subsidiary of a private, internationally recognized minerals exploration and mining company. CMC is well financed and intends to conduct an exploration program using industry leading tools and technology.

Safe Harbor Statements

The following are safe harbor statements under the Private Securities Litigation Reform Act of 1995 for Applied Minerals, Inc. Some statements contained or implied in this news release may be considered forward–looking statements, which by their nature are uncertain. Consequently, actual results could materially differ. For more detailed information concerning how risks and uncertainties could affect the Company's financial results, please refer to Applied Minerals' most recent filings with the SEC. The Company assumes no obligation to update any forward–looking information.